Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
BackgroundRisperidone is a commonly prescribed antipsychotic drug with a potential side effect of weight gain. However, the pathophysiological mechanism is still poorly understood. Here, we sought to identify potential biomarkers of risperidone-induced weight gain by using a targeted metabolomics ap...
Shranjeno v:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2023-04-01
|
| Serija: | Frontiers in Psychiatry |
| Teme: | |
| Online dostop: | https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1144873/full |
| Oznake: |
Brez oznak, prvi označite!
|